Use of antidepressants and benzodiazepine-related hypnotics before and after initiation of TNF-α inhibitors or non-biological systemic treatment in patients with rheumatoid arthritis, psoriatic arthritis or ankylosing spondylitis

[1] El Maghraoui A(2011)Extra-articular manifestations of ankylosing spondylitis: prevalence, characteristics and therapeutic implications Eur J Intern Med 22 554-560

[2] Cather JC(2017)Psoriasis and psoriatic arthritis J Clin Aesthet Dermatol 10 S16-S25

[3] Young M(2010)Rheumatoid arthritis Lancet (London, England) 376 1094-1108

[4] Bergman MJ(2013)The prevalence of depression in rheumatoid arthritis: a systematic review and meta-analysis Rheumatology (Oxford) 52 2136-2148

[5] Scott DL(2017)The risk of depression, suicidal ideation and suicide attempt in patients with psoriasis, psoriatic arthritis or ankylosing spondylitis J Eur Acad Dermatol Venereol 31 1168-1175

[6] Wolfe F(2009)Anti-tumor necrosis factor-alpha therapy is associated with less frequent mood and anxiety disorders in patients with rheumatoid arthritis Psychiatry Clin Neurosci 63 50-55

[7] Huizinga TW(2002)Depression in rheumatoid arthritis: a systematic review of the literature with meta-analysis Psychosom Med 64 52-60

[8] Matcham F(2006)Baseline comorbidity levels in biologic and standard DMARD treated patients with rheumatoid arthritis: results from a national patient register Ann Rheum Dis 65 895-898

[9] Rayner L(2016)Symptoms of depression and anxiety predict treatment response and long-term physical health outcomes in rheumatoid arthritis: secondary analysis of a randomized controlled trial Rheumatology (Oxford) 55 268-278

[10] Steer S(2016)A prospective evaluation of the effects of prevalent depressive symptoms on disease activity in rheumatoid arthritis patients treated with biologic response modifiers Clin Ther 38 1759-72 e3

[1] El Maghraoui A(2011)Extra-articular manifestations of ankylosing spondylitis: prevalence, characteristics and therapeutic implications Eur J Intern Med 22 554-560

[2] Cather JC(2017)Psoriasis and psoriatic arthritis J Clin Aesthet Dermatol 10 S16-S25

[3] Young M(2010)Rheumatoid arthritis Lancet (London, England) 376 1094-1108

[4] Bergman MJ(2013)The prevalence of depression in rheumatoid arthritis: a systematic review and meta-analysis Rheumatology (Oxford) 52 2136-2148

[5] Scott DL(2017)The risk of depression, suicidal ideation and suicide attempt in patients with psoriasis, psoriatic arthritis or ankylosing spondylitis J Eur Acad Dermatol Venereol 31 1168-1175

[6] Wolfe F(2009)Anti-tumor necrosis factor-alpha therapy is associated with less frequent mood and anxiety disorders in patients with rheumatoid arthritis Psychiatry Clin Neurosci 63 50-55

[7] Huizinga TW(2002)Depression in rheumatoid arthritis: a systematic review of the literature with meta-analysis Psychosom Med 64 52-60

[8] Matcham F(2006)Baseline comorbidity levels in biologic and standard DMARD treated patients with rheumatoid arthritis: results from a national patient register Ann Rheum Dis 65 895-898

[9] Rayner L(2016)Symptoms of depression and anxiety predict treatment response and long-term physical health outcomes in rheumatoid arthritis: secondary analysis of a randomized controlled trial Rheumatology (Oxford) 55 268-278

[10] Steer S(2016)A prospective evaluation of the effects of prevalent depressive symptoms on disease activity in rheumatoid arthritis patients treated with biologic response modifiers Clin Ther 38 1759-72 e3